BackZevra Therapeutics Overview
Zevra Therapeutics Inc

Zevra Therapeutics Target Price

Analysts' average 12-month price target for Zevra Therapeutics is $27.

Get informed when a big investor buys or sells

+ Follow

Share Price

$11.26

Average Target Price

$26.83138.3% upside

6 analysts in the last 4 months

High: $35 | Low: $20

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-27Guggenheim$24113.1% upsideOpen
2026-07-27BTIGKambiz Yazdi$24113.1% upsideOpen
2026-07-27Canaccord GenuitySumant Kulkarni$2077.6% upsideOpen
2026-06-10Maxim GroupJason McCarthy$35210.8% upsideOpen
2026-06-10GuggenheimEddie Hickman$29157.5% upsideOpen
2026-06-09Canaccord GenuitySumant Kulkarni$29157.5% upsideOpen
2026-05-08GuggenheimEddie Hickman$25122% upsideOpen
2026-03-10GuggenheimEddie Hickman$23104.3% upsideOpen
2025-12-30H.C. WainwrightBrandon Folkes$26130.9% upsideOpen
2025-11-06Cantor FitzgeraldKristen Kluska$24113.1% upsideOpen
2025-11-06Canaccord Genuity$24113.1% upsideOpen
2025-03-13Guggenheim$2295.4% upsideOpen
2025-03-12JMP Securities$1859.9% upsideOpen
2025-02-04GuggenheimZevra Therapeutics to $$2186.5% upsideOpen
2024-09-24Roth CapitalJonathan Aschoff$2186.5% upsideOpen
2024-09-24Maxim GroupJason McCarthy$25122% upsideOpen
2024-09-24JMP SecuritiesJason Butler$1751% upsideOpen
2024-09-23H.C. WainwrightOren Livnat$2077.6% upsideOpen
2024-09-18Canaccord GenuitySumant Kulkarni$2295.4% upsideOpen

Zevra Therapeutics (ZVRA) FAQ

The latest target price for ZVRA is $27. Investors often review this figure alongside Zevra Therapeutics's historical trend and sector peers before judging valuation or financial health.

Zevra Therapeutics trades near $11.26 while the consensus target sits at $27 (138.3% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting ZVRA's target price ($27), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Zevra Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.